Change of pharmacokinetic parameters of 131I-hippuran caused by heparin.

The radiochemical purity of 131I-hippuran determined by radiochromatographic analysis using Whatman No 3 MM paper and a mixture of n-butanol, acetic acid and water as developer, was 97.3 +/- 1.2%. O-131IB acid and less than 1% of free 131I were separated from the preparation. No radioactivity which would correspond to O-131IB acid was observed on the radiochromatogram when 131I-hippuran was incubated with HSA and heparin. Protein binding of 131I-hippuran as a function of radiochemical purity, and HSA and heparin concentrations were determined by the method of equilibrium dialysis. No effect of radiochemical purity on protein binding of 131I-hippuran was observed, the value obtained being 1.3 +/- 0.1%. Higher HSA concentrations increased protein binding but decreased retention activity on the dialysing membrane. Heparin decreased protein binding of 131I-hippuran by 47%. The biological half-times of excretion of 131I-hippuran with heparin were 4 min for the fast phase and 107 min for the slow phase. The results of biodistribution in experimental animals showed increased localization of 131I-hippuran with heparin in the kidneys and liver during the first 15 min after injection.

Comparative quality control of 99mTc-Pyrophosphate and 99mTc-diphosphonate radiopharmaceuticals.

The results of analysis of 99mTc-Pyrophosphate (99mPyP), taken as a representative of the group of compounds having an organic P-O-P bond, and of the three diphosphonate compounds: methylene diphosphonate (MDP), 2,3-dicarboxy propane diphosphonate (DPD) and ethane-1-hydroxy-1, 1-diphosphonate (EHDP), which differ in their chemical structure, are shown. Also, some physicochemical parameters such as chloroform-water apparent partition coefficient, the osmotic pressure and pH values in final preparations were studied. The radiochemical purity of these radiopharmaceuticals was determined by the two methods: Sephadex chromatography for separation of 99mTc-hydrolysate and TLC on silica gel with 85% methanol for the determination of free 99mTcO-4. The yield of labelling for both methods was over 90%. Also, pharmacokinetic parameters such as binding to the plasma proteins and to erythrocytes were determined. 99mTc-PyP binding to plasma proteins was higher than the binding of diphosphonate compounds. The quantitative distribution of preparations was determined in experimental animals.

Determination of radiochemical purity and pharmacokinetic parameters of 99mTc-sulphur colloid and 99mTc-tin colloid.

Labelling yield and radiochemical purity, higher than 95%, of 99mTc-colloid preparations were determined by using the paper chromatography method. Less than 3% of labelled citric acid, added to the preparation as a buffer solution, has been found in 99mTc-sulphur colloid. High radiochemical purity and optimum size of colloid particles has also been proved by biodistribution studies on experimental animals. The analysis performed has shown that more than 50% of 99mTc-colloid preparations excreted by urine is 99mTcO-, the remaining past 50% being protein bound 99mTc. Biological half-time of excretion of the fast phase is the same for both preparations, i.e. 10 min, while for the slow component it is 120 min in 99mTc-S-colloid and 160 min in 99mTc-Sn colloid.